01 7ASTRAZENECA
01 17960370
02 18383678
03 19012501
04 19050308
05 19050309
06 19132112
07 110117844
01 1Y
02 6Blank
01 4Y
02 3Blank
01 32025-02-07
02 12026-12-20
03 32033-01-04
Patent Expiration Date : 2025-02-07
US Patent Number : 8383678
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205060
Patent Use Code : U-1511
Delist Requested :
Patent Use Description : TREATMENT OF HYPERTRIG...
Patent Expiration Date : 2025-02-07
Patent Expiration Date : 2025-02-07
US Patent Number : 9132112
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205060
Patent Use Code : U-1511
Delist Requested :
Patent Use Description : TREATMENT OF HYPERTRIG...
Patent Expiration Date : 2025-02-07
Patent Expiration Date : 2025-02-07
US Patent Number : 9012501
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205060
Patent Use Code : U-1511
Delist Requested :
Patent Use Description : TREATMENT OF HYPERTRIG...
Patent Expiration Date : 2025-02-07
Patent Expiration Date : 2033-01-04
US Patent Number : 10117844
Drug Substance Claim :
Drug Product Claim :
Application Number : 205060
Patent Use Code : U-2447
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-04
Patent Expiration Date : 2033-01-04
US Patent Number : 9050308
Drug Substance Claim :
Drug Product Claim :
Application Number : 205060
Patent Use Code : U-1511
Delist Requested :
Patent Use Description : TREATMENT OF HYPERTRIG...
Patent Expiration Date : 2033-01-04
Patent Expiration Date : 2033-01-04
US Patent Number : 9050309
Drug Substance Claim : Y
Drug Product Claim :
Application Number : 205060
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2033-01-04
Patent Expiration Date : 2026-12-20
US Patent Number : 7960370
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205060
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-20
